Abstract
Muscarinic M2-receptors allow for divergent modes of allosteric action, depending on the structure of the allosteric modulator. Phthalimido-substituted bis(ammonio)alkane-type modulators belong to the common mode allosteric agents, whereas a physicochemically closely related bispyridinium-oxime with dichlorobenzyl-substituents at both ends is an atypical agent. Here, we compared the actions of stepwise shortened compounds composed of the phthalimido moiety and middle chains of either the bispyridinium- or the bis(ammonio)alkane-type. Allosteric interactions were measured in pig M2 receptors with the orthosteric probe [3H]N-methylscopolamine ([3H]NMS) to label the acetylcholine binding site of the receptors. Dissociation and equilibrium binding experiments revealed parallel structure/activity-relationships in both series of compounds with regard to the cooperativity of interaction with [3H]NMS and to the underlying binding affinities in radioligand-occupied and free receptors. In conclusion, the findings are in line with the hypothesis that the phthalimido-moiety, but not the middle chain, is pivotal for the topology of interaction with the M2-receptor protein.
Similar content being viewed by others
REFERENCES
Christopoulos, A. 2002. Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery. Nat. Rev. Drug Discov. 1:198–210.
Tränkle, C., Andresen, I., Lambrecht, G., and Mohr, K. 1998. M2 receptor binding of the selective antagonist AF-DX 384: Possible involvement of the common allosteric site. Mol. Pharmacol. 53:304–312.
Stockton, J. M., Birdsall, N. J. M., Burgen, A. S. V., and Hulme, E. C. 1983. Modification of the binding properties of the muscarinic receptors by gallamine. Mol. Pharmacol. 23:551–557.
Ehlert, F. J. 1988. Estimation of the affinities of allosteric ligands using radioligand and pharmacological null methods. Mol. Pharmacol. 83:187–194.
Soudijn, W., van Wijngaarden, I., and IJzerman, A. P. 2001. Allosteric modulation of G-protein-coupled receptors. Expert Opin. Ther. Patents 11:1889–1904.
Christopoulos, A. and Kenakin, T. 2002. G-Protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54:323–374.
Tuček, S. and Proška, J. 1995. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:205–212.
Ellis, J. 1997. Allosteric binding sites on muscarinic receptors. Drug Dev. Res. 40:193–204.
Holzgrabe, U. and Mohr, K. 1998. Allosteric modulators of ligand binding to muscarinic acetylcholine receptors. Drug Discovery Today 3:214–222.
Mohr, K., Tränkle, C., and Holzgrabe, U. Structure/activity-relationships of muscarinic allosteric modulators. Receptors and Channels (in the press).
Jakubík, J., Bačáková, L., El-Fakahany, E. E., and Tučcek, S. 1997. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol. Pharmacol. 52:172–179.
Dolezal, V. and Tučcek, S. 1998. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptors agonists. Br. J. Pharmacol. 124:1213–1218.
Birdsall, N. J. M., Farries, T., Gharagozloo, P., Kobayashi, S., Lazareno, S., and Sugimoto, M. 1999. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: Functional studies. Mol. Pharmacol. 55:778–786.
Jakubík, J., Bačáková, L., Lisa, V., El-Fakahany, E. E., and Tučcek, S. 1996. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Natl. Acad. Sci. USA 93:8705–8709.
Jakubík, J., Haga, T., and Tuček, S. 1998. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S] thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry. Mol. Pharmacol. 54:899–906.
Zahn, K., Eckstein, N., Tränkle, C., Sadeé, W., and Mohr, K. 2002. Allosteric modulation of muscarinic receptor signaling: Alcuronium-induced conversion of pilocarpine from an agonist into an antagonist. J. Pharmacol. Exp. Ther. 301:720–728.
Jakubík, J. and Tuček, S. 1995. Positive allosteric interactions on cardiac muscarinic receptors: Effects of chemical modification of disulphide and carboxyl groups. Eur. J. Pharmacol. 289:311–319.
Ellis, J., Seidenberg, M., and Brann, M. R. 1993. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol. Pharmacol. 44:583–588.
Leppik, R. A., Miller, R. C., Eck, M., and Paquet, J. L. 1994. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the M2 muscarinic acetylcholine receptor. Mol. Pharmacol. 45:983–990.
Gnagey, A. L., Seidenberg, M., and Ellis, J. 1999. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol. Pharmacol. 56:1245–1253.
Ellis, J. and Seidenberg, M. 2000. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors. Mol. Pharmacol. 58:1451–1460.
Krejčí, A. and Tuček, S. 2001. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors. Mol. Pharmacol. 60:761–767.
Buller, S., Zlotos, D. P., Mohr, K., and Ellis, J. 2002. Allosteric site on muscarinic acetylcholine receptors: A single amino acid in TM7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands. Mol. Pharmacol. 61:160–168.
Ellis, J. and Seidenberg, M. 1992. Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol. Pharmacol. 42:638–641.
Bejeuhr, G., Holzgrabe, U., Mohr, K., Sürig, U., and v. Petersenn, A. 1992. Molecular modelling and synthesis of potent stabilizers of antagonist binding to M2-cholinoceptors. Pharm. Pharmacol. Lett. 2:100–103.
Tränkle, C. and Mohr, K. 1997. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors. Mol. Pharmacol. 51:674–682.
Schröter, A., Tränkle, C., and Mohr, K. 2000. Modes of allosteric interactions with free and [3H]N-methylscopolamine occupied muscarinic M2 receptors as deduced from buffer dependent potency shifts. Naunyn Schmiedebergs Arch. Pharmacol. 362:512–519.
Kostenis, E., Holzgrabe, U., and Mohr, K. 1994. Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: Comparison with bispyridinium-type allosteric modulators. Eur. J. Med. Chem. 29:947–953.
Kostenis, E., Botero Cid, H. M., Holzgrabe, U., and Mohr, K. 1996. Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors. Eur. J. Pharmacol. 314:385–392.
Botero Cid, H. M., Holzgrabe, U., Kostenis, E., Mohr, K., and Tränkle, C. 1994. Search for the phamacophore of bispyridinium-type allosteric modulators of muscarinic receptors. J. Med. Chem. 37:1439–1445.
Tränkle, C., Kostenis, E., Burgmer, U., and Mohr, K. 1996. Search for lead structures to develop new allosteric modulators of muscarinic receptors. J. Pharmacol. Exp. Ther. 279:926–933.
Krejčí, A. and Tuček, S. 2002. Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex. Mol. Pharmacol. 61:1267–1272.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.
Lazareno, S. and Birdsall, N. J. M. 1995. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48:362–378.
Tränkle, C., Mies-Klomfaß, E., Botero Cid, M. H., Holzgrabe, U., and Mohr, K. 1998. Identification of a [3H]ligand for the common allosteric site of muscarinic acetylcholine M2 receptors. Mol. Pharmacol. 54:139–145.
Christopoulos, A. 1998. Assessing the distribution of parameters in models of ligand-receptor interaction: To log or not to log. Trends Pharmacol. Sci. 19:351–357.
Raasch, A., Scharfenstein, O., Tränkle, C., Holzgrabe, U., and Mohr, K. 2002. Elevation of ligand binding to muscarinic M2 acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators. J. Med. Chem. 45:3809–3812.
Lazareno, S., Popham, A., and Birdsall, N. J. M. 2000. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: Identification of a second allosteric site. Mol. Pharmacol. 58:194–207.
Kostenis, E. and Mohr, K. 1996. Composite action of allosteric modulators on ligand binding. Trends Pharmacol. Sci. 17:443–444.
Lysíková, M., Havlas, Z., and Tuček, S. 2001. Interaction between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: Potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists. Neurochem. Res. 26:383–394.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilsbach, R., Großmüller, M., Alptüzün, V. et al. Cooperative Interactions at M2 Muscarinic Acetylcholine Receptors: Structure/Activity Relationships in Stepwise Shortened Bispyridinium- and Bis(Ammonio)Alkane-Type Allosteric Modulators. Neurochem Res 28, 667–673 (2003). https://doi.org/10.1023/A:1022858414900
Issue Date:
DOI: https://doi.org/10.1023/A:1022858414900